BNP PARIBAS ARBITRAGE, SA
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1166588
NEW YORK, NY
Position in IMDX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$209
-$16 QoQ
Shares Held
64
+113.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMDX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $1,383,399,743 across 39 Diagnostics & Research names. IMDX ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
665,128 | $326,930,365 | |
| 2 | DHR |
Danaher Corp /De/
|
1,376,341 | $260,954,253 | |
| 3 | A |
Agilent Technologies, Inc.
|
1,417,666 | $161,585,570 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
66,634 | $84,038,800 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
138,726 | $77,948,752 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
392,886 | $67,002,778 | |
| 7 | DGX |
Quest Diagnostics Inc
|
270,281 | $52,969,670 | |
| 8 | GH |
Guardant Health, Inc.
|
572,650 | $52,895,680 |
All Filings in IMDX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $209 | 64 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $225 | 30 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $99 | 30 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $718 | 238 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $636 | 208 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $495 | 208 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||